Company intelligence / Profile preview

Chereso

Panchkula, Haryana, Indiacheresohealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Chereso manufactures and exports standardized herbal extracts, nutraceuticals, APIs from plant sources, and dietary supplements. The company has developed clinically evaluated ingredients such as Furocyst for PCOS. It holds over thirty patents/trademarks and operates two state-of-the-art manufacturing facilities with global regulatory certifications. Products are distributed worldwide across North America, Europe, Asia-Pacific, Africa, Middle East & Latin America.

Therapeutic areas: EndocrinologyImmunology
Modalities: Small molecule (plant-derived)Natural extractNutraceuticals/Herbal supplementActive pharmaceutical ingredient (API)Finished dosage forms
Industry: Food & Nutrition

Drug pipeline

6 assets

FENFURO

Commercial

Indications: Diabetes

5 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Chereso.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chereso.

Explore the full profile